• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.73% Nasdaq Up 0.60%

    Incyte Corporation (INCY)

    -NasdaqGS
    139.48 Down 0.41(0.29%) Mar 28, 4:00PM EDT
    |After Hours : 140.00 Up 0.52 (0.37%) Mar 28, 6:59PM EDT
    Prev Close:139.89
    Open:139.46
    Bid:122.39 x 300
    Ask:N/A
    1y Target Est:144.53
    Beta:1.81592
    Earnings Date:May 8 - May 12 (Est.)
    Day's Range:138.38 - 141.34
    52wk Range:67.94 - 153.15
    Volume:1,852,551
    Avg Vol (3m):2,477,810
    Market Cap:28.43B
    P/E (ttm):258.30
    EPS (ttm):0.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INCYDown 0.29%28.43B
    1 0.00%N/A
    CELGDown 0.34%96.80B
    AMGNDown 0.12%121.30B

    Key Statistics

    Forward P/E (1 yr):146.82
    P/S (ttm):23.96
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :0.30
    Quarterly EPS Est (Mar-17) :-0.83
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):11.81

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback